[1] Weissleder R, Mahmood U. Molecular imaging[J]. Radiology, 2001, 219(2):316-333.
[2] Weissleder R. Molecular imaging:exploring the next frontier[J]. Radiology, 1999, 212(3):609-614.
[3] Frangioni JV, Hajjar RJ. In vivo tracking of stem cells for clinical trials in cardiovascular disease[J]. Circulation, 2004, 110(21):3378-3383.  doi: 10.1161/01.CIR.0000149840.46523.FC
[4] Politi LS. MR-based imaging of neural stem cells[J]. Neuroradiology, 2007, 49(6):523-534.
[5] Modo M, Mellodew K, Cash D, et al. Mapping transplanted stem cell migration after a stroke:a serial, in vivo magnetic resonance imaging study[J]. NeuroImage, 2004, 21(1):311-317.  doi: 10.1016/j.neuroimage.2003.08.030
[6] Ahrens ET, Bulte JW. Tracking immune cells in vivo using magnetic resonance imaging[J]. Nat Rev Immunol, 2013, 13(10):755-763.  doi: 10.1038/nri3531
[7] Anderson SA, Glod J, Arbab AS, et al. Noninvasive Mr imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model[J]. Blood, 2005, 105(1):420-425.  doi: 10.1182/blood-2004-06-2222
[8] 林冰影, 张景峰, 张敏鸣.不同粒径和浓度超顺磁性氧化铁MR信号特征的实验研究[J].浙江大学学报:医学版, 2010, 39(2):125-129.
[9] Neri M, Maderna C, Cavazzin C, et al. Efficient in vitro labeling of human neural precursor cells with superparamagnetic Iron oxide particles:relevance for in vivo cell tracking[J]. Stem Cells, 2008, 26(2):505-516.
[10] Frank JA, Miller BR, Arbab AS, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic Iron oxides and transfection agents[J]. Radiology, 2003, 228(2):480-487.
[11] Vandsburger M. Cardiac cell tracking with MRI reporter genes:welcoming a new field[J]. Curr Cardiovasc Imaging Rep, 2014, 7(2):9250.  doi: 10.1007/s12410-013-9250-0
[12] Naumova AV, Reinecke H, Yarnykh V, et al. Ferritin overexpression for noninvasive magnetic resonance Imaging-Based tracking of stem cells transplanted into the heart[J]. Mol Imaging, 2010, 9(4):201-210.
[13] Janjic JM, Ahrens ET. Fluorine-containing nanoemulsions for MRI cell tracking[J]. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2010, 1(5):492-501.
[14] Walczak P, Kedziorek DA, Gilad AA, et al. Applicability and limitations of MR tracking of neural stem cells with asymmetric cell division and rapid turnover:the case of the shiverer dysmyelinated mouse brain[J]. Magn Reson Med, 2007, 58(2):261-269.  doi: 10.1002/mrm.21280
[15] Elizabeth J, Sutton Tobias D, Henning Bernd J, et al. Cell tracking with optical imaging[J]. Eur Radiol, 2008, 18(10):2021-2032.
[16] Dhawan AP, D′Alessandro B, Fu X. Optical imaging modalities for biomedical applications[J]. IEEE Rev Biomed Eng, 2010, 3:69-92.  doi: 10.1109/RBME.2010.2081975
[17] Gao Y, Cui Y, Chan JK, et al. Stem cell tracking with optically active nanoparticles[J]. Am J Nucl Med Mol Imaging, 2013, 3(3):232-246.
[18]

Shah K. Imaging neural stem cell fate in mouse model of glioma[J/OL]. Curr Protoc Stem Cell Biol, 2009[2014-09-26]. http://www. ncbi. nlm. nih. gov/pubmed/19306259
[19] Hong H, Yang Y, Zhang Y, et al. Non-invasive cell tracking in cancer and cancer therapy[J]. Curr Top Med Chem, 2010, 10(12):1237-1248.  doi: 10.2174/156802610791384234
[20] Baba S, Cho SY, Ye Z, et al. How reproducible is bioluminescent imaging of tumor cell growth? Single time point versus the dynamic measurement approach[J]. Mol Imaging, 2007, 6(5):315-322.
[21] Ezzat T, Dhar DK, Malago M, et al. Dynamic tracking of stem cells in an acute liver failure model[J]. World J Gastroenterol, 2012, 18(6):507-516.  doi: 10.3748/wjg.v18.i6.507
[22] Li K, Zhang ZP, Luo M, et al. Multifunctional ferritin cage nanostructures for fluorescence and Mr imaging of tumor cells[J]. Nanoscale, 2012, 4(1):188-193.
[23] Detante O, Valable S, De Fraipont F, et al. Magnetic resonance imaging and fluorescence labeling of clinical-grade mesenchymal stem cells without impacting their phenotype:study in a rat model of stroke[J]. Stem Cells Transl Med, 2012, 1(4):333-341.
[24] Lee HY, Li ZB, Chen K, et al. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic(RGD)- Conjugated radiolabeled Iron oxide nanoparticles[J]. J Nucl Med, 2008, 49(8):1371-1379.
[25] Choi JS, Park JC, Nah H, et al. A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging[J]. Angew Chem Int Ed Engl, 2008, 47(33):6259-6262.  doi: 10.1002/anie.200801369
[26] Benyettou F, Lalatonne Y, Chebbi I, et al. A multimodal magnetic resonance imaging nanoplatform for cancer theranostics[J]. Phys Chem Chem Phys, 2011, 13(21):10020-10027.  doi: 10.1039/c0cp02034f